Husk at læse hele vores research disclaimer på https://www.inderes.dk/disclaimer.
Amniotics develops and manufactures stem cell therapies in our own GMP certified facility. Amniotics was born out of the discovery of a novel source of stem cells in full-term amniotic fluid.
Based on a decade of research at the internationally recognized Lund University Stem Cell Center and Hospital, Amniotics is pioneering the harvesting and propagation of tissue specific neonatal quality mesenchymal stem cells (MSC).
Amniotics is listed at Nasdaq First North Growth Market in Stockholm.